MedTrace Logo

Gabapentin Treatment of Alcohol Dependence

NCT00391716 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-11-10

Study results available
· View outcomes & findings →

Summary

Gabapentin treatment for alcohol dependence

Conditions

  • Alcoholism
  • Alcohol Dependence

Interventions

DRUG

Gabapentin 900mg

900 mg gabapentin daily for 12 weeks

BEHAVIORAL

behavioral counseling

The manual for standardized alcohol-related behavioral counseling was developed by Drs. Barbara Mason and Anita Goodman. The manual is available at alcoholfree.info.

DRUG

placebo

lactose capsule compounded to mimic gabapentin capsules

DRUG

gabapentin 1800mg

1800 mg gabapentin daily for 12 weeks

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • The Scripps Research Institute

    lead OTHER

Principal Investigators

  • Barbara J. Mason, PhD · The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2009-07-31
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391716 on ClinicalTrials.gov